COVID-19 versus seasonal influenza: myocardial injury and prognostic importance.
COVID-19
Cardiovascular disease
Prognosis
Seasonal influenza
Journal
BMC infectious diseases
ISSN: 1471-2334
Titre abrégé: BMC Infect Dis
Pays: England
ID NLM: 100968551
Informations de publication
Date de publication:
13 Jun 2022
13 Jun 2022
Historique:
received:
11
10
2021
accepted:
25
05
2022
entrez:
12
6
2022
pubmed:
13
6
2022
medline:
15
6
2022
Statut:
epublish
Résumé
Acute myocardial injury is associated with poor prognosis in respiratory tract infections. We aimed to highlight the differences in prevalence of myocardial injury and its impact on prognosis in patients with COVID-19 compared to those with seasonal influenza. This was a single-center prospective cohort study with a historical control group. 300 age-/sex-matched SARS-CoV-2 and seasonal influenza positive patients were enrolled. Myocardial injury was assessed by electrocardiogram (ECG), transthoracic echocardiography and biomarkers including high-sensitivity troponin-I. All patients were followed-up for 30 days after enrollment for all-cause mortalitiy, admission to the intensive care unit (ICU) and mechanical ventilation. Right ventricular distress was more common in COVID-19 whereas pathological ECG findings and impaired left ventricular function were more prevalent among influenza patients. COVID-19 patients suffered from a higher percentage of hypertension and dyslipidaemia. Contrary to COVID-19, pericardial effusion at admission was associated with poor outcome in the influenza group. Severe course of disease and respiratory failure resulted in significantly higher rates of ICU treatment and mechanical ventilation in COVID-19 patients. Although distribution of myocardial injury was similar, significantly fewer cardiac catheterizations were performed in COVID-19 patients. However, number of cardiac catheterizations was low in both groups. Finally, 30-day mortality was significantly higher in COVID-19 compared to influenza patients. In adults requiring hospitalization due to COVID-19 or seasonal influenza, cardiovascular risk factors and signs of myocardial distress differ significantly. Furthermore, cardiovascular comorbidities may impair prognosis in COVID-19 patients to a higher degree than in their influenza counterparts.
Sections du résumé
BACKGROUND
BACKGROUND
Acute myocardial injury is associated with poor prognosis in respiratory tract infections. We aimed to highlight the differences in prevalence of myocardial injury and its impact on prognosis in patients with COVID-19 compared to those with seasonal influenza.
METHODS
METHODS
This was a single-center prospective cohort study with a historical control group. 300 age-/sex-matched SARS-CoV-2 and seasonal influenza positive patients were enrolled. Myocardial injury was assessed by electrocardiogram (ECG), transthoracic echocardiography and biomarkers including high-sensitivity troponin-I. All patients were followed-up for 30 days after enrollment for all-cause mortalitiy, admission to the intensive care unit (ICU) and mechanical ventilation.
RESULTS
RESULTS
Right ventricular distress was more common in COVID-19 whereas pathological ECG findings and impaired left ventricular function were more prevalent among influenza patients. COVID-19 patients suffered from a higher percentage of hypertension and dyslipidaemia. Contrary to COVID-19, pericardial effusion at admission was associated with poor outcome in the influenza group. Severe course of disease and respiratory failure resulted in significantly higher rates of ICU treatment and mechanical ventilation in COVID-19 patients. Although distribution of myocardial injury was similar, significantly fewer cardiac catheterizations were performed in COVID-19 patients. However, number of cardiac catheterizations was low in both groups. Finally, 30-day mortality was significantly higher in COVID-19 compared to influenza patients.
CONCLUSIONS
CONCLUSIONS
In adults requiring hospitalization due to COVID-19 or seasonal influenza, cardiovascular risk factors and signs of myocardial distress differ significantly. Furthermore, cardiovascular comorbidities may impair prognosis in COVID-19 patients to a higher degree than in their influenza counterparts.
Identifiants
pubmed: 35692037
doi: 10.1186/s12879-022-07488-y
pii: 10.1186/s12879-022-07488-y
pmc: PMC9188910
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
539Subventions
Organisme : Deutsche Forschungsgemeinschaft
ID : 190538538
Organisme : Deutsche Forschungsgemeinschaft
ID : 374031971 - TRR 240
Organisme : Deutsche Forschungsgemeinschaft
ID : 335549539-GRK2381
Informations de copyright
© 2022. The Author(s).
Références
Lancet Respir Med. 2021 Mar;9(3):251-259
pubmed: 33341155
Cardiovasc Res. 1997 Jul;35(1):2-3
pubmed: 9302340
Blood. 2021 Feb 25;137(8):1061-1071
pubmed: 33512415
Clin Res Cardiol. 2020 May;109(5):531-538
pubmed: 32161990
Am J Pathol. 2015 Jun;185(6):1528-36
pubmed: 25747532
Front Cardiovasc Med. 2021 Jun 04;8:584108
pubmed: 34150860
Heart. 2020 Aug;106(15):1154-1159
pubmed: 32354798
Am J Respir Crit Care Med. 2020 Jul 15;202(2):287-290
pubmed: 32479162
Arterioscler Thromb Vasc Biol. 2021 Jun;41(6):2080-2096
pubmed: 33910372
Biomed J. 2021 Apr;44(2):183-189
pubmed: 33097442
Cardiovasc Res. 2021 Jan 1;117(1):224-239
pubmed: 33188677
Lancet. 2020 Jun 6;395(10239):1763-1770
pubmed: 32442528
Heart. 2020 Aug;106(15):1127-1131
pubmed: 32499236
Crit Care Med. 2020 Apr;48(4):451-458
pubmed: 32205590
N Engl J Med. 2009 Aug 13;361(7):680-9
pubmed: 19564631
Infection. 2021 Oct;49(5):965-975
pubmed: 34036458
Infect Dis (Lond). 2021 Feb;53(2):111-121
pubmed: 33170050
J Am Coll Cardiol. 2018 Oct 30;72(18):2231-2264
pubmed: 30153967
Thromb Haemost. 2021 Nov;121(11):1417-1426
pubmed: 33634444
JAMA. 2012 Jun 20;307(23):2526-33
pubmed: 22797452
Lancet. 2017 Aug 12;390(10095):697-708
pubmed: 28302313
J Infect. 2010 Jul;61(1):60-5
pubmed: 20430056
Clin Res Cardiol. 2020 Dec;109(12):1491-1499
pubmed: 32537662
Heart Lung. 2021 Nov-Dec;50(6):914-918
pubmed: 34428736
Med Etika Bioet. 2002 Spring-Summer;9(1-2):12-9
pubmed: 16276663